IPO - AiXin Life International, Inc.

Form Type: S-1/A

Filing Date: 2025-04-15

Corporate Action: Ipo

Type: Update

Accession Number: 000164117225004875

Filing Summary: This document is an amended registration statement for AiXin Life International, Inc., under the Securities Act of 1933. The company is conducting a public offering of common stock, proposing to sell 2,500,000 shares at an expected price of $4.00 per share, with a total value of approximately $10,000,000. The offering is on a firm commitment basis, underwritten by Boustead Securities, LLC. AiXin Life International, Inc. primarily operates through subsidiaries in China, including companies such as Chengdu AiXinZhonghong Biological Technology Co., Ltd., Chengdu Aixin Shangyang Hotel Management Co. Ltd., and Chengdu Aixintang Pharmacies. The document details the organizational structure of the company, noting that all significant operations are conducted through its Chinese subsidiaries. It also includes information about the prospective market for its stock and the regulatory framework surrounding the offering.